Phan AT - Search Results

1

Neuroendocrine tumors: novel approaches in the age of targeted therapy.

Phan AT, Yao JC. Phan AT, et al. Oncology (Williston Park). 2008 Dec;22(14):1617-23; discussion 1623-4, 1629. Oncology (Williston Park). 2008. PMID: 19198220 Free article.

2

Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study.

Yao JC, Phan AT, Chang DZ, Wolff RA, Hess K, Gupta S, Jacobs C, Mares JE, Landgraf AN, Rashid A, Meric-Bernstam F. Yao JC, et al. Among authors: phan at. J Clin Oncol. 2008 Sep 10;26(26):4311-8. doi: 10.1200/JCO.2008.16.7858. J Clin Oncol. 2008. PMID: 18779618 Free PMC article. Clinical Trial.

3

New strategies for advanced neuroendocrine tumors in the era of targeted therapy.

Dong M, Phan AT, Yao JC. Dong M, et al. Among authors: phan at. Clin Cancer Res. 2012 Apr 1;18(7):1830-6. doi: 10.1158/1078-0432.CCR-11-2105. Epub 2012 Feb 15. Clin Cancer Res. 2012. PMID: 22338018 Review.

4

Everolimus in advanced pancreatic neuroendocrine tumors: the clinical experience.

Yao JC, Phan AT, Jehl V, Shah G, Meric-Bernstam F. Yao JC, et al. Among authors: phan at. Cancer Res. 2013 Mar 1;73(5):1449-53. doi: 10.1158/0008-5472.CAN-12-3923. Epub 2013 Feb 22. Cancer Res. 2013. PMID: 23436795 Review.

5

Perfusion computed tomography as functional biomarker in randomized run-in study of bevacizumab and everolimus in well-differentiated neuroendocrine tumors.

Yao JC, Phan AT, Hess K, Fogelman D, Jacobs C, Dagohoy C, Leary C, Xie K, Ng CS. Yao JC, et al. Among authors: phan at. Pancreas. 2015 Mar;44(2):190-7. doi: 10.1097/MPA.0000000000000255. Pancreas. 2015. PMID: 25426617 Free PMC article. Clinical Trial.

6

Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study.

Phan AT, Halperin DM, Chan JA, Fogelman DR, Hess KR, Malinowski P, Regan E, Ng CS, Yao JC, Kulke MH. Phan AT, et al. Lancet Oncol. 2015 Jun;16(6):695-703. doi: 10.1016/S1470-2045(15)70136-1. Epub 2015 May 5. Lancet Oncol. 2015. PMID: 25956795 Free PMC article. Clinical Trial.

7

Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma.

Ajani JA, Lee FC, Singh DA, Haller DG, Lenz HJ, Benson AB 3rd, Yanagihara R, Phan AT, Yao JC, Strumberg D. Ajani JA, et al. Among authors: phan at. J Clin Oncol. 2006 Feb 1;24(4):663-7. doi: 10.1200/JCO.2005.04.2994. J Clin Oncol. 2006. PMID: 16446338 Clinical Trial.

8

Treatment options for metastatic neuroendocrine tumors.

Phan AT, Yao JC, Evans DB. Phan AT, et al. Surgery. 2008 Dec;144(6):895-8. doi: 10.1016/j.surg.2008.10.003. Surgery. 2008. PMID: 19040994 No abstract available.

9

Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junction.

Ajani JA, Correa AM, Walsh GL, Komaki R, Lee JH, Vaporciyan AA, Rice DC, Yao JC, Maru DM, Hofstetter WL, Phan AT, Swisher SG. Ajani JA, et al. Among authors: phan at. Cancer. 2010 Apr 1;116(7):1656-63. doi: 10.1002/cncr.24935. Cancer. 2010. PMID: 20143431 Free article. Clinical Trial.

10

Chromogranin A and neuron-specific enolase as prognostic markers in patients with advanced pNET treated with everolimus.

Yao JC, Pavel M, Phan AT, Kulke MH, Hoosen S, St Peter J, Cherfi A, Öberg KE. Yao JC, et al. Among authors: phan at. J Clin Endocrinol Metab. 2011 Dec;96(12):3741-9. doi: 10.1210/jc.2011-0666. Epub 2011 Oct 12. J Clin Endocrinol Metab. 2011. PMID: 21994954 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

309 results

Search Page

Filters